Randomized double-blind controlled trial of patient-controlled epidural analgesia after gynecological abdominal surgery with levobupivacaine 0.125% or ropivacaine 0.2%

Randomized double-blind controlled trial of patient-controlled epidural analgesia after gynecological abdominal surgery with levobupivacaine 0.125% or ropivacaine 0.2% - Controlled trial of patient-controlled epidural analgesia after gynecological abdominal surgery with levobupivacaine 0.125% or ropivacaine 0.2%

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026931

Enrollment

120

Registered

2017-04-10

Start date

2017-04-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

PCEA using levobupivacaine 0.125% PCEA using ropivacaine 0.2%

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Elective gynecological abdminal surgery 2.Combination of general anesthesia and epidural anesthesia 3.Age over 20years 4.ASA physical status classification 1 or 2

Exclusion criteria

Exclusion criteria: 1.Malignant tumor surgery 2.Cesarean section 3.Allergy of the amide-type local anesthetic 4.Contraindication of the epidural anaesthesia 5.History of the neurologic disease 6.Treatment of choronic pain 7.Poorly understand usage of PCEA

Design outcomes

Primary

Measure	Time frame
Cumulative dose of the 48hour local anesthetic obtained from the mechanical PCA pump	—

Secondary

Measure	Time frame
1.VAS at rest 2.VAS at move 3.use of analgesics 4.PCA push and administration 5.blood pressure lowering 6.moter blockade 7.ambulation	—

Countries

Japan

Contacts

Public ContactTetsuya Hasegawa

Toho University Omori Medical Center Department of pharmacy

thasegawa@med.toho-u.ac.jp03-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026